Jia Xuan Kee

Jia Xuan Kee

Auto-generated profile, based on publicly available information

Jia Xuan Kee

Department of Chemistry, Faculty of Science

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in Chemical Science
Verified
Journal Article
Open access
PDF file
JZJiao Xia Zou
Jiao Xia Zou
MCMeng Rui Chang
Meng Rui Chang
NKNikita A. Kuznetsov
Nikita A. Kuznetsov
JKJia Xuan Kee
Jia Xuan Kee
MBMaria Babak
Maria Babak
WAWee Han Ang
Wee Han Ang
Immunogenic cell death (ICD) has attracted enormous attention over the past decade due to its unique characteristics in cancer cell death and its role in activating innate and adaptive immune responses against tumours. Many efforts have been dedicated to screening, identifying and discovering ICD inducers, resulting in the validation of several based on metal complexes. In this review, we provide a comprehensive summary of current metal-based ICD inducers, their molecular mechanisms for triggering ICD initiation and subsequent protective antitumour immune responses, along with considerations for validating ICD both in vitro and in vivo. We also aim to offer insights into the future development of metal complexes with enhanced ICD-inducing properties and their applications in potentiating antitumour immunity.

23 September 2025 in Chemical Reviews
Verified
Journal Article
Open access
JKJia Xuan Kee
Jia Xuan Kee
NYNICOLETTE YAU
NICOLETTE YAU
RMRam Pravin Kumar Muthuramalingam
Ram Pravin Kumar Muthuramalingam
XWXinyi Wang
Xinyi Wang
WCWei Heng Chng
Wei Heng Chng
GPGiorgia Pastorin
Giorgia Pastorin
Colorectal cancer (CRC) remains a significant global health challenge, ranking third in incidence and second in mortality among cancers worldwide. This review addresses the complex landscape of CRC, focusing on incidence, mortality trends, preventive strategies, and the evolving therapeutic approaches, particularly highlighting the role of platinum-based drugs like oxaliplatin (OXP). It also underscores the increasing burden of CRC, with factors such as westernized diets, aging populations, and genetic predispositions contributing to its prevalence. Therapeutically, early detection greatly enhances survival rates, emphasizing the importance of regular colonoscopies and stool tests. For advanced CRC, chemotherapy remains pivotal, with OXP as a cornerstone treatment despite its associated chemotherapy-induced peripheral neurotoxicity (CIPN). The review explores innovative strategies to overcome challenges related to chemotherapy, such as drug resistance and side effects, highlighting recent developments in the field, such as Pt(IV) prodrugs and immunotherapeutic approaches to enhance efficacy while minimizing toxicity. Additionally, this manuscript examines experimental models for drug screening, emphasizing the role of murine models and advanced 3D in vitro systems in CRC research. Overall, the review advocates for a comprehensive approach, integrating prevention, early detection, and personalized treatments to alleviate the global burden of CRC.